EA201591185A1 - Применение пидотимода для лечения псориаза - Google Patents

Применение пидотимода для лечения псориаза

Info

Publication number
EA201591185A1
EA201591185A1 EA201591185A EA201591185A EA201591185A1 EA 201591185 A1 EA201591185 A1 EA 201591185A1 EA 201591185 A EA201591185 A EA 201591185A EA 201591185 A EA201591185 A EA 201591185A EA 201591185 A1 EA201591185 A1 EA 201591185A1
Authority
EA
Eurasian Patent Office
Prior art keywords
psoriasis
treatment
pidotimode
application
pidotimod
Prior art date
Application number
EA201591185A
Other languages
English (en)
Inventor
Маурицио Касерини
Федерико Майлланд
Original Assignee
Полихем С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Полихем С.А. filed Critical Полихем С.А.
Publication of EA201591185A1 publication Critical patent/EA201591185A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Настоящее изобретение направлено на применение пидотимода или его физиологически приемлемой соли для лечения псориаза. В целях терапии настоящее изобретение, пидотимод или его физиологически приемлемую соль, можно применять системно или местно.
EA201591185A 2012-12-19 2012-12-19 Применение пидотимода для лечения псориаза EA201591185A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/076088 WO2014094840A1 (en) 2012-12-19 2012-12-19 Use of pidotimod to treat psoriasis

Publications (1)

Publication Number Publication Date
EA201591185A1 true EA201591185A1 (ru) 2016-02-29

Family

ID=47520054

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591185A EA201591185A1 (ru) 2012-12-19 2012-12-19 Применение пидотимода для лечения псориаза

Country Status (31)

Country Link
US (1) US20150328191A1 (ru)
EP (1) EP2934521B1 (ru)
JP (1) JP6051315B2 (ru)
KR (1) KR20150095773A (ru)
CN (1) CN104869994B (ru)
AR (1) AR094027A1 (ru)
AU (1) AU2012396942A1 (ru)
BR (1) BR112015011391A2 (ru)
CA (1) CA2887878A1 (ru)
CY (1) CY1118645T1 (ru)
DK (1) DK2934521T3 (ru)
EA (1) EA201591185A1 (ru)
ES (1) ES2617235T3 (ru)
HK (1) HK1210937A1 (ru)
HR (1) HRP20161666T1 (ru)
HU (1) HUE031846T2 (ru)
IL (1) IL239429A0 (ru)
LT (1) LT2934521T (ru)
MA (1) MA38155B1 (ru)
ME (1) ME02560B (ru)
MX (1) MX2015008104A (ru)
PH (1) PH12015501210A1 (ru)
PL (1) PL2934521T3 (ru)
PT (1) PT2934521T (ru)
RS (1) RS55436B1 (ru)
SG (1) SG11201503270UA (ru)
SI (1) SI2934521T1 (ru)
SM (1) SMT201700072B (ru)
TN (1) TN2015000142A1 (ru)
WO (1) WO2014094840A1 (ru)
ZA (1) ZA201502573B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015036009A1 (en) * 2013-09-10 2015-03-19 Polichem S.A. Pidotimod for use in the treatment of inflammation-associated diseases
EA201892190A1 (ru) 2016-03-29 2019-04-30 Янссен Байотек, Инк. Лечение псориаза антителом к ил-12 и/или ил-23 с возрастанием интервала между введениями дозы
CN105943505A (zh) * 2016-05-26 2016-09-21 杭州百诚医药科技股份有限公司 一种匹多莫德药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231723B (it) 1989-08-11 1991-12-21 Poli Ind Chimica Spa Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmaceutiche che li contengono
US5594015A (en) * 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
WO2003018011A1 (en) * 2001-08-24 2003-03-06 Wyeth Holdings Corporation 5-(substituted)-5-(substitutedsulfonyl or sulfanyl)thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase

Also Published As

Publication number Publication date
IL239429A0 (en) 2015-07-30
AU2012396942A1 (en) 2015-07-02
US20150328191A1 (en) 2015-11-19
TN2015000142A1 (en) 2016-10-03
CN104869994B (zh) 2016-10-12
MA38155B1 (fr) 2016-09-30
JP6051315B2 (ja) 2016-12-27
WO2014094840A1 (en) 2014-06-26
EP2934521A1 (en) 2015-10-28
PT2934521T (pt) 2017-03-03
RS55436B1 (sr) 2017-04-28
CA2887878A1 (en) 2014-06-26
AU2012396942A2 (en) 2015-07-30
HRP20161666T1 (hr) 2017-01-27
KR20150095773A (ko) 2015-08-21
ME02560B (me) 2017-02-20
ZA201502573B (en) 2016-11-30
HUE031846T2 (hu) 2017-08-28
SG11201503270UA (en) 2015-07-30
BR112015011391A2 (pt) 2017-07-11
SMT201700072B (it) 2017-03-08
MA38155A1 (fr) 2016-02-29
ES2617235T3 (es) 2017-06-15
PL2934521T3 (pl) 2017-06-30
PH12015501210A1 (en) 2015-08-17
SI2934521T1 (sl) 2017-03-31
LT2934521T (lt) 2016-12-27
EP2934521B1 (en) 2016-11-30
DK2934521T3 (en) 2017-02-06
CN104869994A (zh) 2015-08-26
HK1210937A1 (en) 2016-05-13
CY1118645T1 (el) 2017-07-12
AR094027A1 (es) 2015-07-08
MX2015008104A (es) 2015-11-06
JP2016503043A (ja) 2016-02-01

Similar Documents

Publication Publication Date Title
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
EA201591616A1 (ru) Трифторметил-замещенные аннелированные пиримидины и их применение
EA201991484A1 (ru) Лекарственные формы энзалутамида
TR201901886T4 (tr) DNA-PK inhibitörleri.
EA201491854A1 (ru) Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств
CR20120653A (es) Compuestos heterocíclicos, su preparación y su aplicación terapéutica
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
UY35745A (es) Derivados sustituidos de fenilalanina
UY34843A (es) Tratamiento de enfermedades inflamatorias oculares usando laquinimod
UY34543A (es) Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica.
EA201591185A1 (ru) Применение пидотимода для лечения псориаза
UA117809C2 (uk) Похідні бендамустину, споріднені сполуки та їхнє медичне застосування для лікування раку
CY1118633T1 (el) Χρηση pidotimod για την θεραπευτικη αγωγη ατοπικης δερματιτιδας
EA201690709A1 (ru) Применение одипарцила в лечении мукополисахаридоза
MX369774B (es) Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
MX2013006526A (es) Dosis de los derivados de arilsulfonamida.
UA113065C2 (xx) Композиція для нанесення на шкіру та її застосування
MY177715A (en) Use of pidotimod to treat atopic dermatitis
GEP20176633B (en) Use of pidotimod to treat psoriasis
PH12015502304A1 (en) Use of pidotimod to treat irritable bowel syndrome
UY33788A (es) Derivados de arilsulfonamida para la prevención o el tratamiento de trastornos oftalmológicos específicos
PE20151159A1 (es) Uso de pidotimod para tratar la dermatitis atopica